Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 11220 | 933 | 28.6 | 60% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 124 | 23152 | HEPATITIS B VIRUS//CHRONIC HEPATITIS B//HEPATITIS B |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | BIO NANOCAPSULE | Author keyword | 21 | 85% | 1% | 11 |
| 2 | RECOMBINANT HEPATITIS B SURFACE ANTIGEN | Author keyword | 15 | 88% | 1% | 7 |
| 3 | PRE S1 | Author keyword | 4 | 67% | 0% | 4 |
| 4 | BIONANOCAPSULE | Author keyword | 4 | 75% | 0% | 3 |
| 5 | PRES1 | Author keyword | 4 | 29% | 1% | 11 |
| 6 | PRE S2 | Author keyword | 4 | 46% | 1% | 6 |
| 7 | PRE S PROTEINS | Author keyword | 3 | 100% | 0% | 3 |
| 8 | SECRETABILITY | Author keyword | 3 | 100% | 0% | 3 |
| 9 | PRE S2 ANTIGEN | Author keyword | 3 | 60% | 0% | 3 |
| 10 | ANTIBODY ENGN UNIT | Address | 2 | 33% | 1% | 6 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | BIO NANOCAPSULE | 21 | 85% | 1% | 11 | Search BIO+NANOCAPSULE | Search BIO+NANOCAPSULE |
| 2 | RECOMBINANT HEPATITIS B SURFACE ANTIGEN | 15 | 88% | 1% | 7 | Search RECOMBINANT+HEPATITIS+B+SURFACE+ANTIGEN | Search RECOMBINANT+HEPATITIS+B+SURFACE+ANTIGEN |
| 3 | PRE S1 | 4 | 67% | 0% | 4 | Search PRE+S1 | Search PRE+S1 |
| 4 | BIONANOCAPSULE | 4 | 75% | 0% | 3 | Search BIONANOCAPSULE | Search BIONANOCAPSULE |
| 5 | PRES1 | 4 | 29% | 1% | 11 | Search PRES1 | Search PRES1 |
| 6 | PRE S2 | 4 | 46% | 1% | 6 | Search PRE+S2 | Search PRE+S2 |
| 7 | PRE S PROTEINS | 3 | 100% | 0% | 3 | Search PRE+S+PROTEINS | Search PRE+S+PROTEINS |
| 8 | SECRETABILITY | 3 | 100% | 0% | 3 | Search SECRETABILITY | Search SECRETABILITY |
| 9 | PRE S2 ANTIGEN | 3 | 60% | 0% | 3 | Search PRE+S2+ANTIGEN | Search PRE+S2+ANTIGEN |
| 10 | BIO NANOCAPSULES | 2 | 67% | 0% | 2 | Search BIO+NANOCAPSULES | Search BIO+NANOCAPSULES |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | BIONANOCAPSULES | 21 | 90% | 1% | 9 |
| 2 | POLYMERIZED HUMAN | 18 | 47% | 3% | 28 |
| 3 | CHIMPANZEE ALBUMINS | 17 | 70% | 2% | 14 |
| 4 | PRE S1 | 12 | 86% | 1% | 6 |
| 5 | 3RD GENERATION VACCINE | 10 | 73% | 1% | 8 |
| 6 | PRE S2 REGION | 10 | 48% | 2% | 15 |
| 7 | PRE S REGION | 7 | 35% | 2% | 17 |
| 8 | P PASTORIS | 6 | 71% | 1% | 5 |
| 9 | S REGION | 5 | 39% | 1% | 11 |
| 10 | SHBS ANTIBODY INDUCTION | 4 | 75% | 0% | 3 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
|---|---|---|---|---|
| T-CELL AND B-CELL RECOGNITION OF HEPATITIS-B VIRAL-ANTIGENS | 1988 | 122 | 35 | 69% |
| Enhanced immune response to hepatitis B vaccination through immunization with a Pre-S1/Pre-S2/S Vaccine | 2015 | 2 | 72 | 22% |
| BIO-NANOCAPSULE-LIPOSOME CONJUGATES FOR IN VIVO PINPOINT DRUG AND GENE DELIVERY | 2009 | 12 | 27 | 41% |
| IMMUNE-RESPONSE TO HEPATITIS-B VIRUS PROTEINS - RELEVANCE OF THE MURINE MODEL | 1991 | 52 | 99 | 40% |
| GENETIC AND MOLECULAR-BASIS FOR T-CELL AND B-CELL RECOGNITION OF HEPATITIS-B VIRAL-ANTIGENS | 1987 | 67 | 30 | 57% |
| Nanoparticles for human liver-specific drug and gene delivery systems: in vitro and in vivo advances | 2009 | 20 | 67 | 16% |
| THE STRUCTURE OF HEPATITIS-B SURFACE-ANTIGEN AND ITS ANTIGENIC SITES | 1987 | 29 | 11 | 82% |
| Development of pre-S2-containing hepatitis B vaccine produced by recombinant DNA technology | 1996 | 0 | 8 | 100% |
| BIOLOGICAL AND CLINICAL-SIGNIFICANCE OF PRE-S ANTIGENS AND CORRESPONDING ANTIBODIES IN HEPATITIS B-VIRUS INFECTION | 1990 | 2 | 42 | 88% |
| BIOLOGICAL STANDARDS FOR HEPATITIS-B VIRUS ASSAYS | 1992 | 3 | 12 | 50% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | ANTIBODY ENGN UNIT | 2 | 33% | 0.6% | 6 |
| 2 | MEDEVA DEV | 2 | 67% | 0.2% | 2 |
| 3 | REAGENTS DIAGNOST | 1 | 100% | 0.2% | 2 |
| 4 | ROGEN INC | 1 | 100% | 0.2% | 2 |
| 5 | MONOCLONAL ANTIBODY PROD | 1 | 23% | 0.5% | 5 |
| 6 | BIO VENTURE 311 | 1 | 50% | 0.1% | 1 |
| 7 | DEV BIOTECHNOL UNIT | 1 | 50% | 0.1% | 1 |
| 8 | DIRECT QUAL CONTROL | 1 | 50% | 0.1% | 1 |
| 9 | JIAGNSU PROV INFECT DIS | 1 | 50% | 0.1% | 1 |
| 10 | MED SCI SHINAGAWA KU | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000251700 | INTERNAL MED MOL BIOL 2//HEPADNAVIRUS//DUCK HEPATITIS B VIRUS |
| 2 | 0.0000148270 | IGM ANTI HBC//ANTI HBC IGM//HBVDNA |
| 3 | 0.0000112325 | HEPATITIS B VACCINE//HEPATITIS B//HEPATITIS B VACCINATION |
| 4 | 0.0000105899 | HEPATITIS B VIRUS//PRECORE//PRECORE MUTATION |
| 5 | 0.0000073594 | PREDETERMINED SPECIFICITY//SYNTHETIC ANTIGENIC SITE//B CELL EPITOPE PREDICTION |
| 6 | 0.0000068870 | PEPTIDE PROT CHEM//PHYSICOCHEM UNIT//QUIM PEPTIDS PROT |
| 7 | 0.0000060737 | ASPARTYL BETA HYDROXYLASE//HUMBUG//ASPARTYL ASPARAGINYL BETA HYDROXYLASE |
| 8 | 0.0000058772 | PATHOGENESE VIRUS HEPATITE B//WOODCHUCK HEPATITIS VIRUS//WOODCHUCK |
| 9 | 0.0000050852 | IMMUNOLOGICAL AGENTS//INT MED PROGRAMME//CLINICAL PREDICTIONS |
| 10 | 0.0000049003 | 2 MU M PLASMID//SUC2 PROMOTER//PLASMID STABILITY |